LRRK2 mutations in PD have also been shown to exacerbate inflammatory responses [46], while the loss of LRRK2 has been associated with decreased proinflammatory signaling and neuroprotective effects against LPS and α-synuclein-induced neurodegeneration [47]. This evidence concerns the gene LRRK2 and Parkinson disease.